Interstitial lung disease associated with immune-checkpoint inhibitors in malignant diseases

被引：0
|
作者：
Yamagata, A. [1 ]
Yokoyama, T. [1 ]
Fukuda, Y. [1 ]
Ishida, T. [1 ]
机构：
[1] Kurashiki Cent Hosp, Dept Resp Med, Kurashiki, Okayama, Japan
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1307P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients
    Delaunay, Myriam
    Cadranel, Jacques
    Lusque, Amelie
    Meyer, Nicolas
    Gounaut, Valerie
    Moro-Sibilot, Denis
    Michot, Jean-Marie
    Raimbourg, Judith
    Girard, Nicolas
    Guisier, Florian
    Planchard, David
    Metivier, Anne-Cecile
    Tomasini, Pascale
    Dansin, Eric
    Perol, Maurice
    Campana, Marion
    Gautschi, Oliver
    Fruh, Martin
    Fumet, Jean-David
    Audigier-Valette, Clarisse
    Couraud, Sebastien
    Dalle, Stephane
    Leccia, Marie-Therese
    Jaffro, Marion
    Collot, Samia
    Prevot, Gregoire
    Milia, Julie
    Mazieres, Julien
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (02)
  • [2] Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients (vol 50, 1700050, 2017 )
    Delaunay, Myriam
    Cadranel, Jacques
    Lusque, Amelie
    Meyer, Nicolas
    Gounant, Valerie
    Moro-Sibilot, Denis
    Michot, Jean-Marie
    Raimbourg, Judith
    Girard, Nicolas
    Guisier, Florian
    Planchard, David
    Metivier, Anne-Cecile
    Tomasini, Pascale
    Dansin, Eric
    Perol, Maurice
    Campana, Marion
    Gautschi, Oliver
    Fruh, Martin
    Fumet, Jean-David
    Audigier-Valette, Clarisse
    Couraud, Sebastien
    Dalle, Stephane
    Leccia, Marie-Therese
    Jaffro, Marion
    Collot, Samia
    Prevot, Gregoire
    Milia, Julie
    Mazieres, Julien
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (05)
  • [3] Antitumor effects are augmented in mouse models of interstitial-lung disease caused by immune-checkpoint inhibitors
    Arita, Masashi
    Watanabe, Satoshi
    Yanagimura, Naohiro
    Mishina, Yuko
    Sato, Miyuki
    Shoji, Satoshi
    Ichikawa, Kosuke
    Kondo, Rie
    Tanaka, Junta
    Sakagami, Takuro
    Koya, Toshiyuki
    Kikuchi, Toshiaki
    CANCER RESEARCH, 2018, 78 (13)
  • [4] Role of immune-checkpoint inhibitors in lung cancer
    Jain, Prantesh
    Jain, Chhavi
    Velcheti, Vamsidhar
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2018, 12
  • [5] Neurological toxicities associated with immune-checkpoint inhibitors
    Touat, Mehdi
    Talmasov, Daniel
    Ricard, Damien
    Psimaras, Dimitri
    CURRENT OPINION IN NEUROLOGY, 2017, 30 (06) : 659 - 668
  • [6] Immune-checkpoint profiles for T cells in bronchoalveolar lavage fluid of patients with immune-checkpoint inhibitor-related interstitial lung disease
    Suzuki, Kunihiro
    Yanagihara, Toyoshi
    Matsumoto, Koichiro
    Kusaba, Hitoshi
    Yamauchi, Takuji
    Ikematsu, Yuki
    Tanaka, Kentaro
    Otsubo, Kohei
    Inoue, Hiroyuki
    Yoneshima, Yasuto
    Iwama, Eiji
    Arimura-Omori, Masako
    Harada, Eiji
    Hamada, Naoki
    Okamoto, Isamu
    Nakanishi, Yoichi
    INTERNATIONAL IMMUNOLOGY, 2020, 32 (08) : 547 - 557
  • [7] The Evolving Role of Immune-Checkpoint Inhibitors in Malignant Pleural Mesothelioma
    Borgeaud, Maxime
    Kim, Floryane
    Friedlaender, Alex
    Lococo, Filippo
    Addeo, Alfredo
    Minervini, Fabrizio
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (05)
  • [8] Interstitial lung disease induced by immune-checkpoint inhibitors correlates with prognosis of advanced non-small cell lung cancer patients
    Sugano, T.
    Seike, M.
    Saito, Y.
    Takano, N.
    Hisakane, K.
    Takahashi, S.
    Tanaka, T.
    Kashiwada, T.
    Nakamichi, S.
    Takeuchi, S.
    Miyanaga, A.
    Minegishi, Y.
    Noro, R.
    Kubota, K.
    Gemma, A.
    ANNALS OF ONCOLOGY, 2019, 30 : 617 - 617
  • [9] Economic analyses of immune-checkpoint inhibitors to treat lung cancer
    Vergnenegre, Alain
    Chouaid, Christos
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2021, 21 (03) : 365 - 371
  • [10] Solid organ transplant rejection associated with immune-checkpoint inhibitors
    Saberianfar, S.
    Nguyen, L. S.
    Manouchehri, A.
    Lebrun-Vignes, B.
    Moslehi, J. J.
    Johnson, D. B.
    Hertig, A.
    Salem, J. -E.
    ANNALS OF ONCOLOGY, 2020, 31 (04) : 543 - 544
12345